Drugs / protein yeast hydrolysate
last change Jun 2025 re-read 2 minutes ago

protein yeast hydrolysate

Developed for
morbid obesity
Investigated by
Imperial Clinical Trials Unit (ICTU) · Imperial College London · Nestlé

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT06689501 Oct 2024 → Jun 2025 morbid obesity Nestlé Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as protein yeast hydrolysate “The study product is blend of ingredients composed of L-carnitine tartrate, dihydrocapsiate and protein yeast hydrolysate (DNF-10®).” NCT06689501
Route Oral “Participants will consume a total of 4 capsules a day split in two servings.” NCT06689501